• Springer Nature H1 2026 revenue rose to €939.8 million; underlying growth was 6.2%.
• Adjusted operating profit climbed to €246.2 million; underlying growth was 7.7%.
• Research revenue increased to €748 million; underlying growth was 7.2%, with adjusted operating profit rising to €228.7 million on 8.2% underlying growth.
• Free cash flow rose €64 million to €268 million; net debt was €1.2 billion with a 1.6x leverage ratio.
• 2026 guidance lifted to underlying revenue growth of about 6% from 5%-6%; underlying AOP margin improvement seen at at least 30 basis points.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Springer Nature AG & Co. KgaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2377286_en) on August 05, 2026, and is solely responsible for the information contained therein.